Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N0LZ
|
|||
Former ID |
DNC012099
|
|||
Drug Name |
3-Naphthalen-1-yl-pyrrolidine
|
|||
Synonyms |
3-(1-NAPHTHYL)PYRROLIDINE; 178483-14-2; 3-(naphthalen-1-yl)pyrrolidine; CHEMBL311972; 3-Naphthalen-1-yl-pyrrolidine; SCHEMBL8878356; CTK5J7733; BDBM50290933; 5967AD; AKOS011343953
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H15N
|
|||
Canonical SMILES |
C1CNCC1C2=CC=CC3=CC=CC=C32
|
|||
InChI |
1S/C14H15N/c1-2-6-13-11(4-1)5-3-7-14(13)12-8-9-15-10-12/h1-7,12,15H,8-10H2
|
|||
InChIKey |
KTMCVZGLGDBGJZ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Regioselective synthesis of 3-aryl substituted pyrrolidines via palladium catalyzed arylation: pharmacological evaluation for central dopaminergic and serotonergic activity, Bioorg. Med. Chem. Lett. 7(3):241-246 (1997). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.